Proliferating cell nuclear antigen (PCNA) has been shown to be of prognostic significance in some gastrointestinal tumors. Immunohistochemical analysis was performed to determine whether PCNA is useful for predicting the outcome of patients with squamous cell carcinoma of the esophagus. Using a mouse monoclonal antibody, PC 10, the expression of PCNA was studied in resected squamous cell carcinomas of the esophagus from 59 patients who had undergone curative esophagectomy. None had received any preceding therapy. The proliferation rate was assessed in terms of the percentage of the PCNA-positive nuclear area relative to the total area of cancer nuclei using a cell analysis system (CAS). Clinicopathological variables including PCNA staining were assessed in relation to prognosis. (Jpn J Clin Oncol 26: [405][406][407][408][409][410] 1996) 
Introduction
Squamous cell carcinoma of the esophagus is one of the most challenging malignant neoplasms because of its poor prognosis. Due to early diagnosis and effective combination therapy with cisplatin, fluorouracil, and radiation, the survival rate of patients has recently been increasing.'"" In esophageal carcinoma, the staging is one of the factors that correlated with prognosis. ' However, it is known that some patients can survive long after surgery, irrespective of disease stage. Such clinical phenomena suggest that there is a variation in the biological malignancy of this tumor among individual patients. Certain parameters such as the expression of epidermal growth factor receptor (EGFR) are widely accepted as factors which can indicate the malignant potential of the tumor. 10 '"' Proliferating cell nuclear antigen (PCNA) is a 36-kDa nuclear protein that has been found to be a useful marker of cell proliferation since its expression and distribution are correlated with the rate of cell proliferation and DNA synthesis in various tumors. 12 ' 13) Expression of PCNA has been shown to be of prognostic value in some gastrointestinal tumors, 14 ' l5) but few reports have examined the correlation of PCNA with the prognosis of squamous cell carcinoma of the esophagus. 16 ' 17) In this study we evaluated the prognostic significance of proliferative activity in squamous cell carcinoma of the esophagus, using a quantitative PCNA immunohistochemical method.
Materials and Methods
The records of 59 patients who had undergone curative esophagectomy for squamous cell carcinoma of the esophagus were reviewed. Patients who had been given preoperative therapy for the tumor or those with another primary cancers were excluded. Operative deaths were not included either. Of the patients examined, 53 were men (49 to 83 years of age; mean±SD, 64.8 ±7.7 years) and 6 were women (58.6 ±10.8 years). All pathologic reports and slides were reviewed, and one block for each patient, containing cancer tissue near the cancernoncancer junction, was selected for PCNA immunohistochemical testing. Staging of the patients and histopathological grading of the tumors were based on the TNM classification.
18) Histopathological grades, classified into four, were assigned according to the degree of keratinization.
Immunohistochemistry
All tissues were routinely embedded in paraffin wax within 48 h after fixation in 10% formalin. To determine the degree of preservation and reproducibility considering the duration of fixation, a comparison was made between 11 biopsy samples selected randomly and the surgical materials from the same cases.
Sections were deparaffinized in xylene, rehydrated through alcohol, and then treated for 30 min with 3% H2O2 to block endogenous peroxidase activity. Sections were subsequently washed in phosphate-buffered saline (PBS). A mouse monoclonal antibody against PCNA, PC 10 19) (Dako, Glostrup, Denmark), was used. Sections were incubated with the antibody at 1 : 100 dilution for 18 h at 4°C. Immunohistochemical staining was done using the SAB kit (Nichirei, Tokyo), according to the manufacturer's instructions. Diaminobenzidine (DAB) was used as the chromogen, and the slides were counterstained with methyl green. To ensure consistency of PCNA staining between batches, a known positive control esophageal carcinoma was included in each round. The experiment was repeated if there was any measurable fluctuation in the PCNA staining of this control. Negative controls were included by performing duplicate assays.
Immunostaining Analysis
The proliferation rate was examined as the PCNA index, defined as the percentage of the PCNA-positive area of nuclei stained with DAB relative to the total area of cancer nuclei stained with methyl green or DAB. All cancer cells with stained nuclei were evaluated, but the areas without nuclei showing cancer pearl formation or highly keratinized foci in the centers of the cancer nests were not evaluated. More than 20 random highpower microscopic fields were selected in each section, giving a total cancer cell nuclear area of more than 200,000 /tm 2 , and analyzed by an image analyzer (CAS 200, Cell Analysis Systems Inc., Elmhurst, IL) using the ER/PR program. The regions in the cancer tissue that appeared grossly to be near the cancer-noncancer junction were used for analysis, and the edges of the tissue sections were not included in the analysis because they were not stained consistently.
Statistical Methods
Comparison of the PCNA indices in the two groups was performed using the nonpaired Student's t test. Continuous variables were compared using the Kruskal-Wallis test. Patients with the following conditions were excluded from the survival analysis: stage 0 and I disease, organ metastasis, positive surgical margin, operative death within 30 days, and loss to follow-up. Survival rates were calculated by the Kaplan-Meier method for analysis of censored data. Statistical significance was analyzed by the log-rank test, and differences at P<0.05 were considered to be significant. Prognostic factors were evaluated by Cox's proportional hazard model with a log-linear risk function. 20 
'

Results
A comparative study was made between 11 biopsy specimens (4 from low PCNA cases and 7 from high PCNA cases) and the corresponding surgical specimens, and this revealed an accuracy (correct positive and negative/all cases) of 82% (9/11) and a sensitivity of (correct positive/correct positive and false negative) of 100% (5/5). No false negative case was found.
PCNA immunostaining intensity was accurately evaluable in slides from 59 patients. Such immunostaining was observed in the carcinomatous structures. PCNA was observed mainly in the peripheral non-keratinized cells of cancer nests, and the immunostaining in the central keratinized area was negative in patients with histological grade 1 tumors (Fig. 1) . In the normal esophageal epithelium, PCNA immunoreactivity was observed in the parabasal cells of the second and third layers and in some additional suprabasal cells (Fig. 2) . The staining intensity varied between nuclei, probably because of regulation of PCNA expression during the cell cycle, and the ratio of the PCNA-positive nuclear area within the total cancer cell nuclear area varied within the range 4.4-96.2% with a mean value of 49.4 ±20.4%. Similarly, there was noticeable intratumoral heterogeneity in each case.
To evaluate the association between PCNA staining and patient survival, patients were separated into two groups at a tumor PCNA index of 40%. This separation gave the best prognostic estimates for PCNA, and it was therefore used in survival analyses. Forty patients had high PCNA indices above 40%, and 19 had low PCNA indices below 40%. PCNA staining was correlated with tumor size (P<0.05) and depth (P<0.05), but not with lymph node metastasis. Although the PCNA index was higher in non-keratinizing than in keratinizing cells in the tumor nests, the histological grade was not correlated with PCNA index (Table I) . Patients whose tumors had low PCNA indices had significantly better survival (P<0.05) (Fig. 3) affected survival in multivariate analysis (Table II) . The most important variable was pT of the tumor; survival declined for every increment of grade (P=0.0011).
Discussion
The rate of cellular proliferation is an important prognostic factor in human malignancies. Cell proliferative activity can be evaluated by several approaches (e.g., mitotic index, incorporation of [ 3 H]thymidine, argyrophilic nuclear organizer regions (AgNOR), flow-cytometric DNA analysis, and immunostaining of DNA polymerase-alpha, KI-67, bromodeoxyuridine and PCNA).
-
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' PCNA is a 36-kDa auxiliary protein of DNA polymerase-5 that functions during the cell cycle. The distribution of PCNA increases through Gl, peaks at the G1S interphase and decreases through G2 phase, but the long half-life of PCNA results in the persistence of staining in noncycling cells. Also, the expression of PCNA in association with DNA repair rather than proliferation should be considered. 12 ' PCNA has been shown in different tumors to correlate well with the KI-67 score 131 or [ 3 H]thymidine uptake. 19 ' PCNA is considered to be a good marker of cell proliferation in routinely processed tissue. 22 ' The major advantage of staining with PC 10 antibody against PCNA is its applicability to formalin-fixed tissues, permitting the study of archival materials for which follow-up data are available. Histopathological and cell proliferation features can therefore be analyzed simultaneously in their local context. Immunohistochemical methods of assessing cell proliferation have advantages over techniques such as flowcytometric S-phase analysis. One of the disadvantages of PCNA staining is the reduction of immunoreactivity by long-term fixation. The comparative study of biopsy samples and surgical materials in this study showed no false negative case, and so the reduction of PCNA immunoreactivity could be considered minimal. Grading of PCNA staining on a semiquantitative basis allowed us to take account of tumor heterogeneity. Wide intratumor and intertumor variation in PCNA staining has been reported in previous studies of solid tumors. 14 -23> Jain et a/.
14 ' assessed the most representative blocks of 93 gastric cancer cases, and 9 of them were assessed for two or more blocks. It was found that 7 cases gave the same grade between blocks in the same patients. In our study, expression of PCNA was higher in cancer tissue near the cancer-noncancer junction than in the central portion of the tumor. Therefore we selected blocks that appeared grossly to lie in the peripheral portion of the tumor in order to exclude any central necrotic region.
The possible relationship between TNM stage and tumor cell proliferation is still unclear. Recent reports have suggested that cell proliferation activity, verified by PCNA staining or other methods, may be of value for histologic grading of certain tumors and as prognostic variable. 15 -24~26 ' However, in some tumors, no significant correlation between PCNA expression and histopathological variables was observed. 27 ' In patients with Barrett's esophagus, the PCNA index of malignant tissue is significantly different from that of benign and dysplastic specimens. 28 ' In squamous cell carcinoma of the esophagus, Hickey et al., i6 > by studying serial endoscopic biopsies from 14 patients, suggested that PCNA expression may be useful for predicting the response of tumors to chemoradiotherapy. Morisaki et al. }1) found that PCNA index correlates with tumor infiltration but not with prognosis in an analysis of 31 surgical specimens. The present study showed a good correlation between prognosis and the cell proliferation index determined by PCNA staining. The grade of PCNA staining was related to tumor size (JP<O.O5) and the depth of invasion (P<0.05). Moreover, pT and pN were independent prognostic factors, but PCNA was not. Because PCNA was correlated with invasion, PCNA might have influenced the prognosis but could not be an independent prognostic factor. Microscopical observation of well differentiated squamous cell cancer tissue showed that PCNA was stained more strongly in peripheral non-keratinized areas than in central keratinized areas, although PCNA index was not correlated with histologic grade. One of the reasons was that histologic grading was determined by studying the whole area of the tumor, whereas PCNA index was defined by studying one region near the cancer-noncancer junction. Another reason was that because the PCNA index was determined in terms of the nuclear area ratio, the area of central cancer pearl formation or regions without nuclei were not counted. The PCNA index of nonkeratinized cells was variable. In the present study, the PCNA index appeared to be a more useful factor for predicting the outcome of esophageal cancer than histological grading.
In esophageal cancer, not only proliferative activity, but also some other molecular biological factors may be correlated with tumor status. High EGFR expression in esophageal tumors is associated with a worse prognosis and high rates of lymph node metastases, and also with a greater likelihood of tumor recurrence.
101 " Although some investigators have reported that accumulation of p53 protein could be a useful prognostic indicator for esophageal cancer, this is still controversial. ' Moreover, the results of DNA analysis in relation to the prognosis of esophageal cancer are conflicting. 35 " 37) We conclude that cellular proliferation activity, determined by PCNA immunohistochemical analysis, is correlated with the survival of patients with advanced squamous cell carcinoma of the esophagus, but is not an independent prognostic factor.
